$2.05 Billion is the total value of Flagship Pioneering Inc.'s 12 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNA | New | MODERNA INC | $897,989,000 | – | 58,807,379 | +100.0% | 43.86% | – |
| RUBY | RUBIUS THERAPEUTICS INC | $615,808,000 | -33.0% | 38,296,526 | 0.0% | 30.07% | -50.5% | |
| EVLO | EVELO BIOSCIENCES INC | $237,216,000 | +6.8% | 18,233,403 | 0.0% | 11.58% | -21.1% | |
| DNLI | DENALI THERAPEUTICS INC | $184,261,000 | -5.0% | 8,918,749 | 0.0% | 9.00% | -29.8% | |
| MCRB | SERES THERAPEUTICS INC | $57,327,000 | -40.4% | 12,682,876 | 0.0% | 2.80% | -56.0% | |
| QTRX | QUANTERIX CORP | $37,178,000 | -14.5% | 2,030,495 | 0.0% | 1.82% | -36.8% | |
| SYRS | SYROS PHARMACEUTICALS INC | $17,849,000 | -53.2% | 3,204,437 | 0.0% | 0.87% | -65.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SERES THERAPEUTICS INC | 29 | Q3 2023 | 68.0% |
| DENALI THERAPEUTICS INC | 24 | Q3 2023 | 50.9% |
| SYROS PHARMACEUTICALS INC | 24 | Q2 2022 | 27.3% |
| MODERNA INC | 20 | Q3 2023 | 76.9% |
| EVELO BIOSCIENCES INC | 20 | Q1 2023 | 41.2% |
| RUBIUS THERAPEUTICS INC | 18 | Q4 2022 | 60.7% |
| Axcella Health Inc | 17 | Q2 2023 | 3.5% |
| KALEIDO BIOSCIENCES INC | 13 | Q1 2022 | 9.5% |
| Foghorn Therapeutics Inc | 12 | Q3 2023 | 6.5% |
| Sana Biotechnology Inc | 11 | Q3 2023 | 18.4% |
View Flagship Pioneering Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-09-15 |
| 4 | 2023-08-15 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-13 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-02-27 |
| 13F-HR | 2023-02-14 |
View Flagship Pioneering Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.